Dmitry Balyasny’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dmitry Balyasny’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,000	Closed	-$3.69M	–	3044
2024 Q4	$3.69M	Buy	30,000 +20,000	+200%	+$2.36M	0.01%	1414
2024 Q3	$1.11M	Buy	+10,000	New	+$1.1M	﹤0.01%	1922
2024 Q1	–	Sell	-50,000	Closed	-$6.15M	–	2865
2023 Q4	$6.15M	Buy	+50,000	New	+$6.24M	0.01%	1050
2014 Q3	–	Sell	-50,000	Closed	-$7.35M	–	787
2014 Q2	$7.35M	Buy	+50,000	New	+$6.93M	0.08%	294

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dmitry Balyasny's JAZZ Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,023 shares worth $487K. The stake represents ﹤0.01% of the portfolio and ranks #2523 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in JAZZ as recently as Q4 2025.

Dmitry Balyasny first reported a position in JAZZ in Q2 2013 and has held it in 34 quarters since. The position peaked at $57.1M in Q3 2025. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Dmitry Balyasny held 2,023 shares of Jazz Pharmaceuticals worth $487K as of Q2 2026.
Jazz Pharmaceuticals was a new Dmitry Balyasny position in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2523 holding.
Dmitry Balyasny first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
Dmitry Balyasny's Jazz Pharmaceuticals position peaked at $57.1M in Q3 2025.
640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.